Reuters logo
6 months ago
BRIEF-Aratana therapeutics anticipates that Entyce will be commercially available by late-2017
February 6, 2017 / 1:43 PM / 6 months ago

BRIEF-Aratana therapeutics anticipates that Entyce will be commercially available by late-2017

Feb 6 (Reuters) - Aratana Therapeutics Inc

* Anticipates that Entyce will be commercially available by late-2017

* Also conducting additional clinical work in other surgical procedures to potentially expand label for Nocita in dogs

* Received response from FDA in connection with post-approval supplement request to transfer manufacturing of Entyce to new vendor

* FDA has requested additional information regarding proposed transfer Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below